Compare ALLO & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | WEYS |
|---|---|---|
| Founded | 2017 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Apparel |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 280.9M |
| IPO Year | 2018 | N/A |
| Metric | ALLO | WEYS |
|---|---|---|
| Price | $1.80 | $31.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $8.27 | N/A |
| AVG Volume (30 Days) | ★ 6.3M | 9.1K |
| Earning Date | 03-12-2026 | 03-03-2026 |
| Dividend Yield | N/A | ★ 3.43% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.54 |
| Revenue | N/A | ★ $279,843,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.40 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.86 | $25.51 |
| 52 Week High | $3.78 | $37.19 |
| Indicator | ALLO | WEYS |
|---|---|---|
| Relative Strength Index (RSI) | 58.49 | 50.06 |
| Support Level | $1.56 | $31.10 |
| Resistance Level | $1.84 | $33.48 |
| Average True Range (ATR) | 0.16 | 0.79 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 67.96 | 44.51 |
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.